Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Services (HCSG) Non-Current Deffered Revenue: 2009-2025

Historic Non-Current Deffered Revenue for Healthcare Services (HCSG) over the last 17 years, with Q3 2025 value amounting to $55.6 million.

  • Healthcare Services' Non-Current Deffered Revenue rose 1376.47% to $55.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.6 million, marking a year-over-year increase of 1376.47%. This contributed to the annual value of $50.0 million for FY2024, which is 2142.72% up from last year.
  • According to the latest figures from Q3 2025, Healthcare Services' Non-Current Deffered Revenue is $55.6 million, which was up 1376.47% from $51.7 million recorded in Q2 2025.
  • In the past 5 years, Healthcare Services' Non-Current Deffered Revenue ranged from a high of $55.6 million in Q3 2025 and a low of $31.8 million during Q3 2022
  • Moreover, its 5-year median value for Non-Current Deffered Revenue was $46.2 million (2024), whereas its average is $43.4 million.
  • Per our database at Business Quant, Healthcare Services' Non-Current Deffered Revenue skyrocketed by 5574.46% in 2021 and then crashed by 3732.24% in 2022.
  • Healthcare Services' Non-Current Deffered Revenue (Quarter) stood at $46.9 million in 2021, then decreased by 27.99% to $33.8 million in 2022, then increased by 21.98% to $41.2 million in 2023, then grew by 21.43% to $50.0 million in 2024, then rose by 11.27% to $55.6 million in 2025.
  • Its Non-Current Deffered Revenue stands at $55.6 million for Q3 2025, versus $51.7 million for Q2 2025 and $46.8 million for Q1 2025.